NDC 0220-1220

Causticum

Causticum

Causticum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Boiron. The primary component is Causticum.

Product ID0220-1220_84b06c38-3360-a64a-e053-2991aa0a7424
NDC0220-1220
Product TypeHuman Otc Drug
Proprietary NameCausticum
Generic NameCausticum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date1983-03-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBoiron
Substance NameCAUSTICUM
Active Ingredient Strength9 [hp_C]/9[hp_C]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0220-1220-41

9 [hp_C] in 1 TUBE (0220-1220-41)
Marketing Start Date1983-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0220-1220-41 [00220122041]

Causticum PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1983-03-03

Drug Details

Active Ingredients

IngredientStrength
CAUSTICUM9 [hp_C]/9[hp_C]

OpenFDA Data

SPL SET ID:84b06c38-335f-a64a-e053-2991aa0a7424
Manufacturer
UNII

NDC Crossover Matching brand name "Causticum" or generic name "Causticum"

NDCBrand NameGeneric Name
0220-1216CausticumCAUSTICUM
0220-1217CausticumCAUSTICUM
0220-1220CausticumCAUSTICUM
0220-1224CausticumCAUSTICUM
0220-1227CausticumCAUSTICUM
0220-1229CausticumCAUSTICUM
0220-1233CausticumCAUSTICUM
0220-1236CausticumCAUSTICUM
0220-1237CausticumCAUSTICUM
0220-1240CausticumCAUSTICUM
0220-1241CausticumCAUSTICUM
0360-0114CAUSTICUMCAUSTICUM
0360-0115CAUSTICUMCAUSTICUM
15631-0118CAUSTICUMCAUSTICUM
15631-0556CAUSTICUMCAUSTICUM
44911-0384CausticumCausticum
60512-6228CAUSTICUMCAUSTICUM
62106-4986CAUSTICUMHahnemanns causticum
63083-7113CausticumCausticum
66096-813CausticumCAUSTICUM
68428-295CausticumCAUSTICUM
71919-171CausticumCAUSTICUM
76472-4040CAUSTICUMCAUSTICUM
76472-4072CAUSTICUMCAUSTICUM
43406-0306Causticum 200CCausticum
68428-041Causticum Kit RefillCAUSTICUM
68428-091Causticum Kit RefillCAUSTICUM
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.